Dai Han Pharmaceutical Co (XKRX:023910) Net Change in Cash : ₩-25,290 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Dai Han Pharmaceutical Co Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Dai Han Pharmaceutical Co's Net Change in Cash for the three months ended in Mar. 2024 was ₩-32,160 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-25,290 Mil.

Dai Han Pharmaceutical Co Net Change in Cash Historical Data

The historical data trend for Dai Han Pharmaceutical Co's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dai Han Pharmaceutical Co Net Change in Cash Chart

Dai Han Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

4,330.08

16,562.37

22,366.83

7,092.30

10,643.97

Dai Han Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															3,773.97	191.38	4,808.41	1,870.21	-32,159.69

Dai Han Pharmaceutical Co Net Change in Cash Calculation

Dai Han Pharmaceutical Co's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	38860.336	+	-17997.605	+	-10331.8	+	113.043
	=	10,644

Dai Han Pharmaceutical Co's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 8013.014 + -40404.742 + 0 + 232.041

= -32,160

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-25,290 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dai Han Pharmaceutical Co Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Dai Han Pharmaceutical Co's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Dai Han Pharmaceutical Co (XKRX:023910) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dai Han Pharmaceutical Co Ltd (XKRX:023910) » Definitions » Net Change in Cash

Comparable Companies

XKRX:082800 XKRX:214390 XKRX:002390 XKRX:176750 XKRX:002620 XKRX:293780 XKRX:067080 XKRX:001360 XKRX:061250 XKRX:011040 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

N/A

Address

8-3, 4-Ga Yangpyeong-dong, Yeongdeungpo-gu, Seoul, KOR

Website

http://www.daihan.com

Dai Han Pharmaceutical Co Ltd is a South Korea based company engages in the manufacture, supply, and distribution of pharmaceutical products such as infusions, injections, drugs used in contrast media, drugs used for external uses and quasi-drugs.

Dai Han Pharmaceutical Co (XKRX:023910) Headlines

No Headlines